IPILIMUMAB Side Effects

6596230-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Hyperbilirubinaemia
on Feb 22, 2010 Male patient from UNITED STATES , 53 years of age, weighting 184.3 lb, was diagnosed with malignant melanoma and was treated with Ipilimumab (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hyperbilirubinaemia. Ipilimumab dosage: 10mg/kg. During the same period patient was treated with BEVACIZUMAB (15mg/kg) (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6509345-2 | Deep Vein Thrombosis, Pain In Extremity
Patient was taking Ipilimumab (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pain in extremity on Dec 18, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 150.8 lb, was diagnosed with malignant melanoma and. Ipilimumab dosage: 10mg/kg. During the same period patient was treated with BEVACIZUMAB (7mg/kg) (View Bevacizumab Review and Bevacizumab Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), EUCERIN CREAM (View Eucerin Cream Review and Eucerin Cream Label ).

6190701-X | Guillain-barre Syndrome, Pneumonia Aspiration
Adverse event was reported on May 04, 2009 by a Male patient taking Ipilimumab (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: FRANCE , 61 years of age, After Ipilimumab was administered, patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?), pneumonia aspiration. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ZOVIRAX (350 Grams X2) (View Zovirax Review and Zovirax Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

6163871-7 | Guillain-barre Syndrome, Pneumonia Aspiration
on Apr 10, 2009 Male patient from LATVIA , 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Ipilimumab (View Usage). Patient experienced the following unwanted or unexpected effects: guillain-barre syndrome (What is guillain-barre syndrome?), pneumonia aspiration. Ipilimumab dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ZOVIRAX (350 Grams X2) (View Zovirax Review and Zovirax Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).


6102476-0 | Erythema Multiforme, Hypocalcaemia, Hypoglycaemia, Metabolic Acidosis, Pneumonia, Sepsis
on Feb 20, 2009 Male patient from UNITED STATES , 64 years of age, was diagnosed with lung neoplasm malignant, cardiac failure congestive, hypertension and was treated with Ipilimumab (View Usage). Patient had the following side effects: erythema multiforme, hypocalcaemia, hypoglycaemia, metabolic acidosis, pneumonia (What is pneumonia?), sepsis (What is sepsis?). Ipilimumab dosage: Third Dose Received On 20-nov-2008. During the same period patient was treated with TAXOL (5th Dose Received On 15-jan-2009) (View Taxol Review and Taxol Label ), CARBOPLATIN (1 Dosage Form - 6 Auc; 5th Dose Received On 15-jan-2009) (View Carboplatin Review and Carboplatin Label ), COREG (Taken 125mg From 03dec2008) (View Coreg Review and Coreg Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6094264-9 | Erythema Multiforme, Hypocalcaemia, Hypoglycaemia, Metabolic Acidosis, Pneumonia, Sepsis
Patient was taking Ipilimumab (View Usage). After Ipilimumab was administered, patient had the following side effects: erythema multiforme, hypocalcaemia, hypoglycaemia, metabolic acidosis, pneumonia (What is pneumonia?), sepsis (What is sepsis?) on Feb 20, 2009 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with lung neoplasm malignant, cardiac failure congestive, hypertension and. Ipilimumab dosage: Third Dose Received On 20-nov-2008. During the same period patient was treated with TAXOL (5th Dose Received On 15-jan-2009) (View Taxol Review and Taxol Label ), CARBOPLATIN (1 Dosage Form - 6 Auc; 5th Dose Received On 15-jan-2009) (View Carboplatin Review and Carboplatin Label ), COREG (Taken 125mg From 03dec2008) (View Coreg Review and Coreg Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6086144-X | Confusional State, Dyspnoea, Erythema Multiforme, Hypocalcaemia, Pneumonia, Pyrexia
Adverse event was reported on Feb 10, 2009 by a Male patient taking Ipilimumab (View Usage) (Dosage: Third Dose Received On 20-nov-2008) was diagnosed with lung neoplasm malignant, cardiac failure congestive, hypertension and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, dyspnoea, erythema multiforme, hypocalcaemia, pneumonia (What is pneumonia?), pyrexia. During the same period patient was treated with TAXOL (5th Dose Received On 15-jan-2009) (View Taxol Review and Taxol Label ), CARBOPLATIN (1 Dosage Form - 6 Auc; 5th Dose Received On 15-jan-2009) (View Carboplatin Review and Carboplatin Label ), COREG (Taken 125mg From 03dec2008) (View Coreg Review and Coreg Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6025635-4 | Sepsis, Skin Exfoliation, Toxic Epidermal Necrolysis
on Dec 23, 2008 Male patient from UNITED STATES , 43 years of age, was diagnosed with lung neoplasm malignant and was treated with Ipilimumab (View Usage). Patient had the following side effects: sepsis (What is sepsis?), skin exfoliation, toxic epidermal necrolysis. Ipilimumab dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ), DEXONA (View Dexona Review and Dexona Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), PALONOSETRON (View Palonosetron Review and Palonosetron Label ), ATENOLOL (Taken 50mg) (View Atenolol Review and Atenolol Label ), AVIL (View Avil Review and Avil Label ). Patient was hospitalized.

6016432-4 | Sepsis, Skin Exfoliation, Toxic Epidermal Necrolysis
on Dec 10, 2008 Male patient from UNITED STATES , 43 years of age, was diagnosed with lung neoplasm malignant and was treated with Ipilimumab (View Usage). After Ipilimumab was administered, patient had the following side effects: sepsis (What is sepsis?), skin exfoliation, toxic epidermal necrolysis. Ipilimumab dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ), DEXONA (View Dexona Review and Dexona Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PALONOSETRON (View Palonosetron Review and Palonosetron Label ), ATENOLOL (Taken 50mg) (View Atenolol Review and Atenolol Label ), AVIL (View Avil Review and Avil Label ). Patient was hospitalized.

5958463-6 | Sepsis, Skin Exfoliation, Toxic Epidermal Necrolysis
Patient was taking Ipilimumab (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?), skin exfoliation, toxic epidermal necrolysis on Nov 06, 2008 from UNITED STATES Additional patient health information: Male patient , 43 years of age, was diagnosed with lung neoplasm malignant and. Ipilimumab dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ), DEXONA (View Dexona Review and Dexona Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PALONOSETRON (View Palonosetron Review and Palonosetron Label ), ATENOLOL (Taken 50mg) (View Atenolol Review and Atenolol Label ), AVIL (View Avil Review and Avil Label ). Patient was hospitalized.

5941229-0 | Sepsis, Skin Exfoliation, Toxic Epidermal Necrolysis
Adverse event was reported on Oct 23, 2008 by a Male patient taking Ipilimumab (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: SINGAPORE , 43 years of age, Patient had the following side effects: sepsis (What is sepsis?), skin exfoliation, toxic epidermal necrolysis. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ), DEXONA (View Dexona Review and Dexona Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PALONOSETRON (View Palonosetron Review and Palonosetron Label ), ATENOLOL (Taken 50mg) (View Atenolol Review and Atenolol Label ), AVIL (View Avil Review and Avil Label ). Patient was hospitalized.

5933034-6 | Sepsis, Skin Exfoliation, Toxic Epidermal Necrolysis
on Oct 23, 2008 Male patient from SINGAPORE , 43 years of age, was diagnosed with lung neoplasm malignant and was treated with Ipilimumab (View Usage). After Ipilimumab was administered, patient had the following side effects: sepsis (What is sepsis?), skin exfoliation, toxic epidermal necrolysis. Ipilimumab dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ), DEXONA (View Dexona Review and Dexona Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PALONOSETRON (View Palonosetron Review and Palonosetron Label ), ATENOLOL (Taken 50mg) (View Atenolol Review and Atenolol Label ), AVIL (View Avil Review and Avil Label ). Patient was hospitalized.

5748014-3 | Dehydration, Intestinal Perforation, Myopathy Steroid
on May 20, 2008 Male patient from UNITED KINGDOM , 71 years of age, was diagnosed with malignant melanoma, colitis and was treated with Ipilimumab (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, intestinal perforation, myopathy steroid. Ipilimumab dosage: . During the same period patient was treated with PREDNISONE TAB (Prednisone Taper.) (View Prednisone Tab Review and Prednisone Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BACTRIM (View Bactrim Review and Bactrim Label ), CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ), FOLATE (View Folate Review and Folate Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

5576755-X | Abdominal Pain, Dehydration, Lymphopenia, Nausea, Neutropenia
Patient was taking Ipilimumab (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), dehydration, lymphopenia, nausea (What is nausea?), neutropenia on Dec 17, 2007 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 103.6 lb, was diagnosed with malignant melanoma, abdominal pain upper, constipation (What is constipation?), prophylaxis of nausea and vomiting and. Ipilimumab dosage: Last Dosed On 17-oct-07. During the same period patient was treated with BMS734019 (MDX 1379) (View Bms734019 (mdx 1379) Review and Bms734019 (mdx 1379) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SENNA (View Senna Review and Senna Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), MAXOLON (View Maxolon Review and Maxolon Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ). Patient was hospitalized.

5571608-5 | Adrenal Insufficiency, Blood Creatinine Increased, Coagulopathy, Dehydration, Hyperkalaemia, Mental Status Changes, Sepsis, Subdural Haematoma
Adverse event was reported on Dec 14, 2007 by a Female patient taking Ipilimumab (View Usage) (Dosage: ) . Location: UNITED STATES , 56 years of age, After Ipilimumab was administered, patient had the following side effects: adrenal insufficiency, blood creatinine increased, coagulopathy, dehydration, hyperkalaemia, mental status changes, sepsis (What is sepsis?), subdural haematoma. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5518521-7 | Adrenal Insufficiency, Coagulopathy, Dehydration, Hyperkalaemia, Mental Status Changes, Renal Failure Acute, Sepsis, Subdural Haematoma
on Nov 08, 2007 Female patient from UNITED STATES , 56 years of age, was treated with Ipilimumab (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, coagulopathy, dehydration, hyperkalaemia, mental status changes, renal failure acute, sepsis (What is sepsis?), subdural haematoma. Ipilimumab dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5315436-4 | Haemolytic Anaemia, Malignant Neoplasm Progression
on Apr 20, 2007 Female patient from UNITED KINGDOM , 37 years of age, weighting 112.4 lb, was diagnosed with malignant melanoma, pain (What is pain?), insomnia, cough, prophylaxis and was treated with Ipilimumab (View Usage). Patient had the following side effects: haemolytic anaemia, malignant neoplasm progression. Ipilimumab dosage: . During the same period patient was treated with MDX 1379 (View Mdx-1379 Review and Mdx-1379 Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), CO DYDRAMOL (Dosage Form = 10/500 Mg) (View Co-dydramol Review and Co-dydramol Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), SIMPLE LINCTUS (View Simple Linctus Review and Simple Linctus Label ), DICLOFENAC 1% GEL (View Diclofenac 1% Gel Review and Diclofenac 1% Gel Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.